Elvis Safary
Overview
Explore the profile of Elvis Safary including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Safary E, Lepeska M, Beran D, Ewen M, Zhaparova A, Rukare J, et al.
PLoS One
. 2024 Aug;
19(8):e0309062.
PMID: 39186719
Aims: Most glucose self-monitoring devices have been developed with high-income countries in mind. We developed a target product profile (TPP) for new glucose self-monitoring technologies for users in low- and...
2.
Marban-Castro E, Muhwava L, Kamau Y, Safary E, Rheeder P, Karsas M, et al.
Trials
. 2024 May;
25(1):331.
PMID: 38773658
Background: Self-monitoring of glucose is an essential component of type 1 diabetes (T1D) management. In recent years, continuous glucose monitoring (CGM) has provided an alternative to daily fingerstick testing for...
3.
Dureab F, Al-Mahbashi T, Sheikh R, Hassan O, Safary E, Al-Qadasi Y
J Rural Med
. 2024 Apr;
19(2):66-75.
PMID: 38655224
Objectives: Many developing countries utilize the services of community health volunteers (CHVs) to enhance healthcare services in underserved regions. Evaluating client satisfaction with CHVs' performance is crucial for ensuring the...
4.
Albitres-Flores L, Perez-Leon S, Bernabe-Ortiz A, Tenorio-Mucha J, Cardenas M, Vetter B, et al.
BMC Health Serv Res
. 2024 Mar;
24(1):401.
PMID: 38553724
Background: Point-of-care testing (POCT) devices are diagnostic tools that can provide quick and accurate results within minutes, making them suitable for diagnosing non-communicable diseases (NCDs). However, these devices are not...
5.
Beltzer A, Kolle J, Gil Miro M, Pleus S, Krauss C, Haug C, et al.
J Diabetes Sci Technol
. 2024 Mar;
:19322968241238146.
PMID: 38477255
Background: Usability engineering analyzes the interaction between the intended users and a device. Its implementation is mandatory for manufacturers to obtain regulatory approval for the European market. The aim of...
6.
Safary E, Beran D, Vetter B, Lepeska M, Abdraimova A, Dunganova A, et al.
BMJ Open
. 2024 Feb;
14(2):e076685.
PMID: 38367964
Aims: Development of non-invasive and minimally invasive glucose monitoring devices (NI-MI-GMDs) generally takes place in high-income countries (HICs), with HIC's attributes guiding product characteristics. However, people living with diabetes (PLWD)...
7.
Performance Assessment of Three Continuous Glucose Monitoring Systems in Adults With Type 1 Diabetes
Kolle J, Eichenlaub M, Mende J, Link M, Vetter B, Safary E, et al.
J Diabetes Sci Technol
. 2023 Sep;
18(6):1424-1432.
PMID: 37758681
Background: FIND, the global alliance for diagnostics, identified the nonmarket-approved continuous glucose monitoring (CGM) system, FiberSense system (FBS), as a potential device for use in low- and middle-income countries. Together...
8.
Tenorio-Mucha J, Busta-Flores P, Lazo-Porras M, Vetter B, Safary E, Moran A, et al.
BMC Health Serv Res
. 2023 Apr;
23(1):412.
PMID: 37118750
Background: Point-of-care testing (POCT) devices may facilitate the delivery of rapid and timely results, providing a clinically important advantage in patient management. The challenges and constraints in the implementation process,...
9.
Mtaita C, Safary E, Simwanza K, Mpembeni R, Likindikoki S, Jahn A
Int J Environ Res Public Health
. 2023 Apr;
20(7).
PMID: 37048027
(1) Background: Gender-based violence (GBV) is widespread globally and has a myriad of adverse effects but is vastly under-reported. Health care workers are among the first responders in GBV. The...
10.
Bernabe-Ortiz A, Carrillo-Larco R, Safary E, Vetter B, Lazo-Porras M
Diabet Med
. 2023 Mar;
40(6):e15089.
PMID: 36929661
Aims: The use of continuous glucose monitors (CGMs) has been shown to have positive impact on diabetes management for people with type 1 diabetes (T1DM), type 2 diabetes (T2DM) and...